473 results on '"Hoeper M"'
Search Results
2. uniPHied: A Novel Platform Study Design for a Phase 2 Clinical Trial to Assess the Safety and Efficacy of AER-901 in Pulmonary Hypertension Associated With Interstitial Lung Disease and Pulmonary Arterial Hypertension
3. Baseline Characteristics From the IMPAHCT Trial of AV-101, Inhaled Imatinib, in Subjects With Pulmonary Arterial Hypertension
4. Impact of Delaying Access to Sotatercept on Patients Living With Pulmonary Arterial Hypertension
5. Pre-planned Study Design Adaptations in UNISUS: A Phase 3, Randomized Superiority Study Comparing the Efficacy, Safety, and Tolerability of Macitentan 75 Mg Versus 10 Mg in Patients With Pulmonary Arterial Hypertension (PAH)
6. ECMO to Go: The “Hannover Artificial Lung - HArt-Lung” Concept
7. Pulmonary hypertension in HFpEF and HFrEF: Pathophysiology, diagnosis, treatment approaches
8. Mosaikperfusion bei chronischer thromboembolischer pulmonale Hypertonie – Vergleich zwischen C-Arm Computertomographie und CT-Angiographie der Pulmonalarterien
9. Morpho-molekulare Pathobiologie des kapillären Netzwerks bei alveolärer kapillärer Dysplasie
10. Reduction of BMPR2 mRNA Expression in Peripheral Blood of Pulmonary Arterial Hypertension Patients: A Marker for Disease Severity?
11. Spezielle Therapieformen
12. Extrakorporale Membranoxygenierung: Prinzip und internistische Indikationen
13. Kommentar zu den 2015 ESC/ERS-Leitlinien zur Diagnostik und Therapie der pulmonalen Hypertonie
14. UNISUS study design: a phase 3 superiority study comparing the efficacy, safety, and tolerability of macitentan 75 mg vs macitentan 10 mg in patients with pulmonary arterial hypertension (PAH)
15. Time-dependent molecular motifs of pulmonary fibrogenesis in COVID-19
16. Impact of pulmonary arterial hypertension on employment, work productivity and quality of life - results of a cross-sectional multi-center study
17. Health disparities and differences in health-care-utilization in patients with pulmonary arterial hypertension
18. Outcomes of patients with initial acute respiratory failure on veno-venous extracorporeal membrane oxygenation (ECMO) requiring additional circulatory support by VVA-ECMO
19. Childhood Trauma in patients with PAH -prevalence, impact on QoL and mental health - a preliminary report
20. Comparative analysis of fibroblastic foci in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis
21. Completeness of right heart catheterization procedures-comparison of community hospitals and a PH center
22. Effect of sotatercept on multicomponent improvement in the PULSAR study
23. A Phase 1 Single and Multiple Ascending Dose (SAD/MAD) Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AV-101, a Novel Inhaled Dry Powder Formulation of Imatinib in Healthy Subjects
24. PULSAR Open-Label Extension: Long-Term Efficacy and Safety of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)
25. Out of the Frying-Pan and into the Fire: Transplant Candidate Selection in Acute Lung Failure Due to SARS-CoV-2 Infection
26. Prolonged Mechanical Ventilation After Lung Transplantation—A Single-Center Study
27. Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.
28. Burden of pulmonary arterial hypertension in Germany
29. ERS statement on chronic thromboembolic pulmonary hypertension
30. Indikation zur Lungen- und Herz-Lungen-Transplantation
31. BIOMARKERS IN THE RESPITE TRIAL INVESTIGATING RIOCIGUAT IN PAH PATIENTS WITH INSUFFICIENT RESPONSE TO PDE-5I: 113
32. Changes in cMRI parameters following a switch to riociguat from phosphodiesterase type 5 inhibitors (PDE5i) in patients with pulmonary arterial hypertension: a REPLACE substudy
33. Treatment effect of selexipag on time to disease progression when initiated early in pulmonary arterial hypertension (PAH) patients: GRIPHON and TRITON pooled analysis
34. Swarm Learning for decentralized and confidential clinical machine learning
35. Der Notfallplan des Krankenhauses bei allgemeingefährlichen Infektionskrankheiten
36. Diagnostik und Therapie der chronischen pulmonalen Hypertonie
37. Swarm Learning for decentralized and confidential clinical machine learning
38. Switching to Riociguat from Phosphodiesterase-5 Inhibitors, With or Without Endothelin Receptor Antagonists, in Patients with Pulmonary Arterial Hypertension: Results from the REPLACE Study
39. Influence of Donor-Recipient Age Mismatch in Young Lung Transplant Recipients
40. 10-Year Experience with Postoperatively-Extended Intraoperative Extracorporeal Membrane Oxygenation in Lung Transplantation for Patients with Severe Pulmonary Hypertension
41. Klassifikation der pulmonalen Hypertonie
42. THERAPEUTIC PLASMA EXCHANGE AS RESCUE THERAPY IN SEVERE SEPSIS AND SEPTIC SHOCK: P17
43. 10-Year Experience with Postoperatively Extended Intraoperative Extracorporeal Membrane Oxygenation in Lung Transplantation for Patients with Severe Pulmonary Hypertension
44. Influence of Donor-Recipient Age Mismatch in Young Lung Transplant Recipients
45. Safety of Riociguat for the Treatment of Pulmonary Arterial Hypertension Associated with Connective Tissue Disease: Data from the EXPERT Registry
46. Safety of Riociguat in Patients Receiving Concomitant Prostanoids: Data from the EXPERT Registry
47. Safety of Riociguat in Patients with Inoperable CTEPH and Persistent/Recurrent CTEPH: Data from the EXPERT Registry
48. Application of Machine Learning in Pulmonary Arterial Hypertension Risk Stratification
49. Extracorporeal Membrane Oxygenation in Nonintubated Patients as Bridge to Lung Transplantation
50. Bridge to Thoracic Organ Transplantation in Patients with Pulmonary Arterial Hypertension Using a Pumpless Lung Assist Device
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.